Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | 130,60 € | 140,60 € | 7,66 % |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 100,90 € | 184,92 € | 83,27 % |
| Icon plc | 18 | 0 | 3 | 0 | 295,70 € | 319,67 € | 8,11 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 250,60 € | 288,66 € | 15,19 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,42 € | 26,01 € | 33,95 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | 42,13 € | 50,33 € | 19,47 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 161,85 € | 184,76 € | 14,16 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 23,02 € | 52,03 € | 126,00 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 373,30 € | 421,61 € | 12,94 % |
| Xencor Inc. | 10 | 1 | 2 | 0 | 22,60 € | 32,58 € | 44,15 % |
| QIAGEN NV | 9 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | 28,40 € | 41,81 € | 47,23 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,85 € | 65,00 € | -4,20 % |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | 8,90 € | 17,78 € | 99,77 % |
| Horizon Pharma plc | 6 | 0 | 0 | 0 | 110,40 € | - | - |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | 32,40 € | 38,99 € | 20,34 % |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | 20,20 € | 45,10 € | 123,24 % |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | 0,47 € | 1,75 € | 273,13 % |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | 27,78 € | 35,99 € | 29,54 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 98,16 € | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,67 € | 3,70 € | 121,82 % |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 115,00 € | 150,00 € | 30,43 % |